微小RNA-3651过表达通过介导核因子κB信号通路抑制人舌癌细胞CAL27的生长与侵袭

吕艳利, 巴凯, 方政

中国临床解剖学杂志 ›› 2023, Vol. 41 ›› Issue (2) : 194-199.

PDF(3884 KB)
PDF(3884 KB)
中国临床解剖学杂志 ›› 2023, Vol. 41 ›› Issue (2) : 194-199. DOI: 10.13418/j.issn.1001-165x.2023.2.13
实验研究

微小RNA-3651过表达通过介导核因子κB信号通路抑制人舌癌细胞CAL27的生长与侵袭

  • 吕艳利1,     巴凯2,    方政2
作者信息 +

microRNA-3651 overexpression inhibiting the growth and invasion of human tongue cancer CAL27 cells by mediating nuclear factor κB signaling pathway

  • Lv Yanli1 , Ba Kai2, Fang Zheng2
Author information +
文章历史 +

摘要

目的    探讨微小RNA(miR)-3651过表达通过介导核因子(NF)-κB信号通路抑制人舌癌细胞CAL27生长与侵袭的机制。  方法    将对数生长期CAL27细胞分为miR-3651 mimic组、mimic-NC组和对照组。采用qRT-PCR检测转染后细胞miR-3651水平,CCK-8检测细胞活力,Transwell检测细胞侵袭能力,划痕实验检测细胞迁移能力,光学显微镜下观察细胞上皮间质转化(epithelial-mesenchymal transition,EMT)的形成,Western blot检测E钙粘蛋白、N钙粘蛋白、波形蛋白、NF-κB p65和p-NF-κB p65蛋白表达。  结果    mimic-NC组与对照组细胞miR-3651水平、细胞活力、侵袭细胞数、细胞迁移率和细胞形态均无明显差异(P>0.05),E钙粘蛋白、N钙粘蛋白、波形蛋白和p-NF-κB p65/NF-κB p65蛋白表达均无明显差异(P>0.05);与mimic-NC组相比,miR-3651 mimic组细胞miR-3651水平升高(P<0.05),培养的细胞第2、3、4 天的活力降低(P<0.05),侵袭细胞数和细胞迁移率降低(P<0.05),细胞E钙粘蛋白表达升高(P<0.05),N钙粘蛋白、波形蛋白和p-NF-κB p65/NF-κB p65蛋白表达下降(P<0.05),显微镜下观察到EMT形成减少。  结论    过表达miR-3651可以抑制CAL27细胞的生长和侵袭,其作用机制可能与抑制NF-κB信号通路磷酸化有关。

Abstract

Objective    To explore the mechanism of microRNA (miR)-3651 overexpression on inhibiting the growth and invasion of human tongue cancer CAL27 cells by mediating nuclear factor (NF)-κB signaling pathway.     Methods    CAL27 cells in logarithmic growth phase were divided into a miR-3651 mimic group, a mimic-NC group and a control group. The level of miR-3651 in each group after transfection was detected by fluorescent quantitative real-time polymerase chain reaction (qRT-PCR). The cell vitality in each group was detected by cell counting kit-8 (CCK-8). The invasion ability of cells in each group was detected by Transwell. The migration ability of cells in each group was detected by scratch assay. The formation of epithelial-mesenchymal transition (EMT) in each group was observed under light microscope. The expression of E-cadherin, N-cadherin, Vimentin, NF-κB p65 and p-NF-κB p65 was detected by Western Blot.    Results    There was no  statistically significant difference in miR-3651 level, activity of cells vitality, number of invasion cells, cells migration rate and cells morphology between mimic-NC group and control group (P>0.05), and there was no significant difference in the expression of E-cadherin, N-cadherin, Vimentin and p-NF-κB p65/NF-κB p65 proteins (P>0.05). Compared with the mimic-NC group, in the miR-3651 mimic group, miR-3651 level was significantly increased (P<0.05), cells vitality were significantly decreased at 2d, 3d, 4d after cell culture (P<0.05), number of invasion cells and cells migration rate were significantly decreased (P<0.05), expression of E-cadherin protein was significantly increased (P<0.05), expression of N-cadherin, Vimentin and p-NF-κB p65/NF-κB p65 proteins were significantly decreased (P<0.05), and EMT formation under microscope was decreased.   Conclusions   miR-3651 overexpression can inhibit the growth and invasion of CAL27 cells, and its action mechanism may be related to the inhibiting the phosphorylation of NF-κB signaling pathway.

关键词

微小RNA-3651;  /   / 核因子κB;  /   / 舌癌;  /   / 侵袭

Key words

 microRNA-3651;  /   / Nuclear factor κB;  /   /  Tongue cancer;  /   /  Invasion

引用本文

导出引用
吕艳利, 巴凯, 方政. 微小RNA-3651过表达通过介导核因子κB信号通路抑制人舌癌细胞CAL27的生长与侵袭[J]. 中国临床解剖学杂志. 2023, 41(2): 194-199 https://doi.org/10.13418/j.issn.1001-165x.2023.2.13
Lv Yanli , Ba Kai, Fang Zheng. microRNA-3651 overexpression inhibiting the growth and invasion of human tongue cancer CAL27 cells by mediating nuclear factor κB signaling pathway[J]. Chinese Journal of Clinical Anatomy. 2023, 41(2): 194-199 https://doi.org/10.13418/j.issn.1001-165x.2023.2.13
中图分类号: R739.86   

参考文献

[1]  Mannelli G, Arcuri F, Agostini T, et al. Classification of tongue cancer resection and treatment algorithm[J]. J Surg Oncol, 2018, 117(5): 1092-1099. DOI: 10.1002/jso.24991.
[2]  Scheff NN, Ye Y, Bhattacharya A, et al. Tumor necrosis factor alpha secreted from oral squamous cell carcinoma contributes to cancer pain and associated inflammation[J]. Pain, 2017, 158(12): 2396-2409. DOI: 10.1097/j.pain.0000000000001044.
[3]  Tajmirriahi N, Razavi SM, Shirani S, et al. Evaluation of metastasis and 5-year survival in oral squamous cell carcinoma patients in Isfahan (2001-2015)[J]. Dent Res J, 2019, 16(2): 117-121. DOI: 10.4103/1735-3327.250974.
[4]  黄天舒, 裴丽鹏. miR-135a靶向PTEN促进宫颈癌细胞增殖、凋亡和转移能力的机制研究[J]. 解放军医药杂志, 2021, 33(1): 20-26. DOI: 10.3969/j.issn.2095-140X.2021.01.005.
[5]  Wang C, Guan S, Chen X, et al. Clinical potential of mir-3651 as a novel prognostic biomarker for esophageal squamous cell cancer[J]. Biochem Biophys Res Commun, 2015, 465(1): 30-34. DOI: 10.1016/j.bbrc.2015.07.109.
[6]  Ries J, Baran C, Wehrhan F, et al. The altered expression levels of miR-186, miR-494 and miR-3651 in OSCC tissue vary from those of the whole blood of OSCC patients[J]. Cancer Biomark, 2019, 24(1): 19-30. DOI: 10.3233/CBM-180032.
[7]  Feng L, Houck JR, Lohavanichbutr P, et al. Transcriptome analysis reveals differentially expressed lncRNAs between oral squamous cell carcinoma and healthy oral mucosa[J]. Oncotarget, 2017, 8(19): 31521-31531. DOI: 10.18632/oncotarget.16358.
[8]  赖思含, 吕素娟, 刘英, 等. miR-218调控SNX4蛋白对急性淋巴E6-1细胞增殖和侵袭的影响[J]. 空军医学杂志, 2018, 34(2): 97-100. DOI: 10.3969/j.issn.2095-3402.2018.02.008.
[9]  Ries J, Baran C, Wehrhan F, et al. Prognostic significance of altered miRNA expression in whole blood of OSCC patients[J]. Oncol Rep, 2017, 37(6): 3467-3474. DOI: 10.3892/or.2017.5639.
[10]熊非, 陈继贵. 微小RNA-3651对结肠癌细胞增殖凋亡及PTEN表达的影响[J]. 临床肿瘤学杂志, 2017, 22(10): 865-868. DOI: 10.3969/j.issn.1009-0460.2017.10.001.
[11]樊玲, 赵景杰. 不同浓度薏苡仁提取物对口腔鳞状细胞癌细胞增殖、迁移和侵袭的影响及作用机制[J]. 临床误诊误治, 2022, 35(4): 108-112. DOI: 10.3969/ j.issn.1002-3429.2022.04.024.
[12]Liao TT, Yang MH. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness[J]. Mol Oncol,2017,11(7):792-804. DOI: 10.1002/1878-0261. 12096.
[13]Wang W, Dong L, Zhao B, et al. E-cadherin is downregulated by microenvironmental changes in pancreatic cancer and induces EMT[J]. Oncol Rep, 2018, 40(3): 1641-1649. DOI: 10.3892/or.2018.6528.
[14]Nguyen T, Mège RM. N-Cadherin and fibroblast growth factor receptors crosstalk in the control of developmental and cancer cell migrations[J]. Eur J Cell Biol, 2016, 95(11): 415-426. DOI: 10.1016/j.ejcb.2016.05.002.
[15]Yin S, Chen FF, Yang GF. Vimentin immunohistochemical expression as a prognostic factor in gastric cancer: a meta-analysis[J]. Pathol Res Pract, 2018, 214(9): 1376-1380. DOI: 10.1016/j.prp.2018.07.014.
[16]Bozhkova DM, Poryazova-Markova EG. The epithelial-mesenchymal transition, e-cadherin and tumor progression in ovarian serous tumors[J]. Folia Med, 2019, 61(2): 296-302. DOI: 10.2478/folmed-2018-0082.
[17]Özeş AR, Miller DF, Özeş ON, et al. NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer[J]. Oncogene, 2016, 35(41): 5350-5361. DOI: 10.1038/onc.2016.75.
[18]张娜, 侯鑫, 张文, 等. 甘草甜素通过调控COX-2/NF-kB通路治疗牙周炎的研究[J]. 分子诊断与治疗杂志, 2021, 13(9): 1469-1472. DOI: 10.3969/j.issn.1674-6929. 2021.09.024.
[19]Wu W, Chen F, Cui X, et al. LncRNA NKILA suppresses TGF-β-induced epithelial-mesenchymal transition by blocking NF-κB signaling in breast cancer[J]. Int J Cancer, 2018, 143(9): 2213-2224. DOI: 10.1002/ijc.31605.
[20]周骢, 伍宝琴, 张齐梅, 等. NF-κB p65、EGF与EGFR在口腔扁平苔藓和口腔鳞癌中的表达及临床意义[J]. 重庆医学, 2017, 46(2): 187-190. DOI: 10.3969/j.issn.1671-8348.2017.02.013.
[21]Menezes SV, Fouani L, Huang MLH, et al. The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin expression in pancreatic cancer cells[J]. Carcinogenesis, 2019, 40(6): 805-818. DOI: 10.1093/carcin/bgy178.

基金

国家自然科学基金(81500826)

PDF(3884 KB)

Accesses

Citation

Detail

段落导航
相关文章

/